HOME >> BIOLOGY >> NEWS
Honey in the medicine cabinet!

Honey researchers to discuss honey's role in medicine and functional foods

Beekeepers, scientists, honey packers and marketing representatives will meet to discuss the future of the beekeeping industry at Apimondia '99, an International Apicultural Congress to be held in Vancouver, BC, September 12 through 18, 1999. This year's theme is "Beekeeping in the New Millennium," and of particular importance is the research into honey's promise for use in medicine, and as a functional food ingredient.

On Tuesday, September 13, Dr. Peter C. Molan, Associate Professor of Biochemistry at the University of Waikato, New Zealand will be the keynote speaker at a plenary session entitled "The Scientific Basis of Apitherapy." In his presentation "Establishing Honey as a Recognized Medicine," Dr. Molan will present the latest research results of the effectiveness of honey against the antibiotic-resistant strains of bacteria that pose a real problem for infection control in hospitals. These so-called "super bugs" are as sensitive as the normal strains to the antibacterial activity of honey.

Numerous clinical trials have demonstrated that honey dressings rapidly clear bacteria from infected wounds. A clinical trial has also demonstrated that simply dressing with honey is just as effective as aggressive surgical removal of infected tissue as a treatment for necrotising fasciitis, the "flesh-eating" bacteria. Dr. Molan will also present research results showing the effectiveness of honey in killing the streptococci that cause that infection.

Dr. Molan heads The University of Waikato Honey Research Unit which is recognized for its expertise in the composition of honey and its antimicrobial activity.

The Honey Research Unit is involved in research on a wide variety of topics such as:

  • Assessment of methods of the effectiveness of the
    '"/>


Contact: Mary Ann Johnson
mjohnson@zfpartners.com
415-268-5421
Zuckerman Fernandes & Partners
26-Aug-1999


Page: 1 2

Related biology news :

1. Honey bee genome assembled
2. Honeybee gene find ends 150-year search
3. Honey bee genome being sequenced
4. Honey the darker the better Has potential as dietary antioxidant
5. USDA establishes Honeybee Genetics and IPM Center
6. Honey shines in athletic research, has scientific community abuzz
7. Honey as healer
8. Honey : Naturess sweetener may increase recuperation after workouts
9. Honey may be the ideal pre-workout energy source
10. Dark Honey Has More Illness-Fighting Agents Than Light Honey
11. Summer Science: Where Have All The Honeybees Gone? UD Bee Guy Asks Why--From America To The Amazon

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Honey the medicine cabinet

(Date:6/15/2015)... DALLAS , June 16, 2015 ... Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), ... Worldwide Forecast to 2020" published by MarketsandMarkets, The Natural ... Billion at a CAGR of 18.4% for the forecast ... Tables and   46 F igures spread   ...
(Date:6/12/2015)... , June 12, 2015  Securus Technologies, a ... solutions for public safety, investigation, corrections and monitoring, ... patent to electronically capture, analyze and identify participants ... recognition methods. This system can: ... an enrollment and subsequent sign-on process is actually ...
(Date:6/9/2015)... 9, 2015   MedNet Solutions , an innovative ... of clinical research, will be providing demonstrations of its ... the 2015 Drug Information Association (DIA) Annual Meeting in ... These presentations will include previews of many exciting new ... upcoming iMedNet 2015 Feature 1 Release. ...
Breaking Biology News(10 mins):Natural Language Processing Market Worth $13.4 Billion by 2020 2Natural Language Processing Market Worth $13.4 Billion by 2020 3Natural Language Processing Market Worth $13.4 Billion by 2020 4Natural Language Processing Market Worth $13.4 Billion by 2020 5Securus Announces Patent Issued for Authorized Presence Verification During Video Visitation 2MedNet To Provide Sneak Peeks Of Its iMedNet "2015 Feature 1 Release" At The DIA Annual Meeting 2MedNet To Provide Sneak Peeks Of Its iMedNet "2015 Feature 1 Release" At The DIA Annual Meeting 3
(Date:7/1/2015)... CA (PRWEB) , ... July 01, 2015 , ... It ... brain injury (TBI) using single photon emission computed tomography (SPECT) according to ... The study, which examined over 20,000 brain scans and is believed to be the ...
(Date:7/1/2015)... July 1, 2015   Decision Resources Group ... advantages of Otezla are its oral administration, alternative ... reported by surveyed rheumatologists. Otezla was the first ... treatment of active psoriatic arthritis in ... of care includes conventional oral treatments including disease-modifying ...
(Date:7/1/2015)... BANGALORE, India , July 1, 2015 ... that uses next generation sequencing technology to empower cancer ... Storrer as chief executive officer. In his expanded ... responsible for all strategy, business expansion and worldwide operations ... served as Strand,s chairman and CEO since its founding ...
(Date:7/1/2015)...  Axovant Sciences Ltd. (NYSE:  AXON), a leading ... dementia, today announced that the company will host ... p.m. EDT following its presentation of RVT-101 clinical ... (AAIC). The event will include ... Lawrence Friedhoff , Chief Development Officer, will present ...
Breaking Biology Technology:Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 2Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 3Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 4Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 2Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 3Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 3
Cached News: